First weight loss pill approved in Australia

Wegovy is a form of semaglutide, a medicine that copies the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone helps regulate blood glucose, appetite and digestion.

This is the first GLP-1 medicine approved in Australia in tablet form.

How does the tablet version compare to injections?

The daily tablet can replace weekly injections, and clinical trials show similar weight loss results.

While Wegovy injections can be taken any time of day, with or without food, the pills must be taken on an empty stomach and 30 minutes before eating.

Both versions of the medicine make you feel fuller for longer. The effectiveness of the pill requires consistency – remembering to take it each day and not eat for half an hour afterwards.

Common side effects include nausea, vomiting, diarrhoea, indigestion and constipation.

More serious side effects are less common but may include kidney injury, pancreatitis and gallbladder problems.

Higher doses of the medicine make negative side effects more severe.

When will Wegovy pills be available?

Wegovy manufacturer Novo Nordisk expects the pills will be available in Australia by the end of 2026.

The pricing is yet to be released. It will likely be around the same as the out-of-pocket costs for the injections, which is between $250 – 450 per month.

Need advice? Chat with your healthcare team

GLP-1 medicines work best when combined with healthy eating, regular physical activity, and appropriate medical support. They are not suitable for everyone, and Diabetes Victoria recommends ongoing guidance from health professionals before and during treatment.  

Diabetes Victoria supports people using GLP-1 medicines through access to accredited practising dietitians and diabetes nurse educators.

Always seek the advice of your doctor or healthcare team if you have questions or concerns about your diabetes management.